Latest filing published 02 Sept 2020 for Sabra Health Care REIT, Inc..
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Based on 4 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -21.0%Entry US$27.02 · Close at T+365 US$21.35
- -15.5%Entry US$27.57 · Close at T+365 US$23.31
- +10.0%Entry US$26.11 · Close at T+365 US$28.71
- +69.0%Entry US$11.14 · Close at T+365 US$18.83
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert A. Ettl: trading record in brief
Robert A. Ettl appears in our data through filings on Sabra Health Care REIT, Inc. shares, published by SEC (Form 4). The record holds 91 filings, for trades running from 17 December 2010 to 31 August 2020.
On the open market, the record shows 4 purchases worth €210k and 1 sale worth €173k. Netting one side against the other leaves €37k of net buying. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 86 share grants. So far in 2020, the count stands at no purchases and 1 sale.
Half of the purchases are above €44k and half below. Ninety days after publication, 4 purchases show a median change of -8.7%, with the price up in 0% of them. They describe history only and say nothing certain about the share price ahead.
The record was last updated on 2 September 2020 with a share grant in Sabra Health Care REIT, Inc. The last insider purchase was made public on 16 June 2015, 4,163 days ago. Typically, a trade is published a median of 4 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Robert A. Ettl
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 505 shares0Common StockSEC:0001510192-20-000107:0
- 7,055 shares0Common StockSEC:0001510192-20-000085:1
- 10,545 shares@ US$18.39100.0% of flowCommon StockSEC:0001510192-20-000085:0
- 390 shares0Common StockSEC:0001510192-20-000069:0
- 395 shares0Common StockSEC:0001510192-20-000039:0
- 1,171 shares0Common StockSEC:0001510192-20-000004:0
- 339 shares0Common StockSEC:0001510192-19-000145:0
- 1,088 shares0Common StockSEC:0001510192-19-000127:0
- 343 shares0Common StockSEC:0001510192-19-000115:0
- 1,269 shares0Common StockSEC:0001510192-19-000093:0
- 5,876 shares0Common StockSEC:0001510192-19-000076:0
- 240 shares0Common StockSEC:0001510192-19-000068:0
- 1,284 shares0Common StockSEC:0001510192-19-000049:0
- 252 shares0Common StockSEC:0001510192-19-000032:0
- 1,137 shares0Common StockSEC:0001510192-19-000010:0
- 230 shares0Common StockSEC:0001510192-18-000129:0
- 810 shares0Common StockSEC:0001510192-18-000114:0
- 184 shares0Common StockSEC:0001510192-18-000101:0
- 862 shares0Common StockSEC:0001510192-18-000087:0
- 4,918 shares0Common StockSEC:0001510192-18-000078:0
- 101 shares0Common StockSEC:0001510192-18-000062:0
- 1,062 shares0Common StockSEC:0001510192-18-000050:0
- 121 shares0Common StockSEC:0001510192-18-000029:0
- 998 shares0Common StockSEC:0001510192-18-000010:0
- 119 shares0Common StockSEC:0001510192-17-000122:0
25 of 91 declarations